These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26426996)

  • 1. c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer.
    Lee KS; Kwak Y; Nam KH; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
    PLoS One; 2015; 10(10):e0139727. PubMed ID: 26426996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer.
    Kwak Y; Yun S; Nam SK; Seo AN; Lee KS; Shin E; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
    J Transl Med; 2017 Aug; 15(1):167. PubMed ID: 28764718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and prognostic value of MET gene copy number gain and chromosome 7 polysomy in primary colorectal cancer patients.
    Seo AN; Park KU; Choe G; Kim WH; Kim DW; Kang SB; Lee HS
    Tumour Biol; 2015 Dec; 36(12):9813-21. PubMed ID: 26159851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favorable prognosis in colorectal cancer patients with co-expression of c-MYC and ß-catenin.
    Lee KS; Kwak Y; Nam KH; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
    BMC Cancer; 2016 Sep; 16(1):730. PubMed ID: 27619912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital polymerase chain reaction for detecting c-MYC copy number gain in tissue and cell-free plasma samples of colorectal cancer patients.
    Lee KS; Nam SK; Seo SH; Park KU; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
    Sci Rep; 2019 Feb; 9(1):1611. PubMed ID: 30733532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast Growth Factor Receptor 1 Gene Copy Number and mRNA Expression in Primary Colorectal Cancer and Its Clinicopathologic Correlation.
    Kwak Y; Nam SK; Seo AN; Kim DW; Kang SB; Kim WH; Lee HS
    Pathobiology; 2015; 82(2):76-83. PubMed ID: 26088290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
    Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
    Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic role of c-MYC amplification in schistosomiasis-associated colorectal cancer.
    Pan W; Wang W; Huang J; Lu K; Huang S; Jiang D; Bu D; Liu J; Jing H; Yao J; Hou Y
    Jpn J Clin Oncol; 2020 Apr; 50(4):446-455. PubMed ID: 32297641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
    Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic role of Cul1 and c-Myc: Prognostic and predictive biomarkers in colorectal cancer.
    Wang W; Deng J; Wang Q; Yao Q; Chen W; Tan Y; Ge Z; Zhou J; Zhou Y
    Oncol Rep; 2017 Jul; 38(1):245-252. PubMed ID: 28560438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method.
    Higaki E; Kuwata T; Nagatsuma AK; Nishida Y; Kinoshita T; Aizawa M; Nitta H; Nagino M; Ochiai A
    Gastric Cancer; 2016 Jan; 19(1):63-73. PubMed ID: 25487305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases.
    Tran TN; Selinger CI; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA
    Clin Lung Cancer; 2016 Jan; 17(1):30-8.e1. PubMed ID: 26395411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous EGFR gene copy number increase is common in colorectal cancer and defines response to anti-EGFR therapy.
    Ålgars A; Avoranta T; Österlund P; Lintunen M; Sundström J; Jokilehto T; Ristimäki A; Ristamäki R; Carpén O
    PLoS One; 2014; 9(6):e99590. PubMed ID: 24940619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis.
    Nakayama N; Yamashita K; Tanaka T; Kawamata H; Ooki A; Sato T; Nakamura T; Watanabe M
    Clin Exp Metastasis; 2016 Jan; 33(1):3-13. PubMed ID: 26563151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of plastin-3 via copy number gain induces the epithelial-mesenchymal transition in circulating colorectal cancer cells.
    Sugimachi K; Yokobori T; Iinuma H; Ueda M; Ueo H; Shinden Y; Eguchi H; Sudo T; Suzuki A; Maehara Y; Mori M; Mimori K
    Ann Surg Oncol; 2014 Oct; 21(11):3680-90. PubMed ID: 24217791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear Notch3 expression is associated with tumor recurrence in patients with stage II and III colorectal cancer.
    Ozawa T; Kazama S; Akiyoshi T; Murono K; Yoneyama S; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kanazawa T; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Morikawa T; Fukayama M; Watanabe T
    Ann Surg Oncol; 2014 Aug; 21(8):2650-8. PubMed ID: 24728738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYC and human telomerase gene (TERC) copy number gain in early-stage non-small cell lung cancer.
    Flacco A; Ludovini V; Bianconi F; Ragusa M; Bellezza G; Tofanetti FR; Pistola L; Siggillino A; Vannucci J; Cagini L; Sidoni A; Puma F; Varella-Garcia M; Crinò L
    Am J Clin Oncol; 2015 Apr; 38(2):152-8. PubMed ID: 25806711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of over-expressed IL-32 in colorectal cancer induces metastasis.
    Yang Y; Wang Z; Zhou Y; Wang X; Xiang J; Chen Z
    World J Surg Oncol; 2015 Apr; 13():146. PubMed ID: 25889282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.